Antitumor Effects of Poplar Propolis on DLBCL SU-DHL-2 Cells

Antitumor Effects of Poplar Propolis on DLBCL SU-DHL-2 Cells

Propolis is resinous natural product produced by Western honeybees using beeswax and plant and bud exudates, which has a wide range of biological activities, including antioxidation, antibacterial, anti-inflammation, immune regulation, antitumor, and so on. Diffuse large B-cell lymphoma (DLBCL) is a...

Full description

Bibliographic Details
Main Authors:	Xiaoqing Liu, Yuanyuan Tian, Ao Yang, Chuang Zhang, Xiaoqing Miao, Wenchao Yang
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Foods
Subjects:	propolis diffuse large B-cell lymphoma SU-DHL-2 cell line proteomics ferroptosis
Online Access:	https://www.mdpi.com/2304-8158/12/2/283

Similar Items

Antitumor Effect of Poplar Propolis on Human Cutaneous Squamous Cell Carcinoma A431 Cells
by: Chuang Zhang, et al.
Published: (2023-11-01)

Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL
by: Wenxia Bian, et al.
Published: (2024-04-01)

Diffuse large B-cell lymphoma with concomitant c-MYC and BCL6 gene rearrangements with primary skin involvement: A case report and a review of literature
by: N G Gabeeva, et al.
Published: (2017-07-01)

<i>N</i>-3-Hydroxy Dodecanoyl-DL-homoserine Lactone (OH-dDHL) Triggers Apoptosis of Bone Marrow-Derived Macrophages through the ER- and Mitochondria-Mediated Pathways
by: Kyungho Woo, et al.
Published: (2021-07-01)

Retrospective Evaluation of Patients Diagnosed with Diffuse Large B Cell Lymphoma (DLBCL)
by: Atakan TEKİNALP, et al.
Published: (2020-12-01)

The Chemical Composition of Brazilian Green Propolis and Its Protective Effects on Mouse Aortic Endothelial Cells against Inflammatory Injury
by: Xiaolan Xu, et al.
Published: (2020-10-01)

Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis
by: Vanja Zeremski, et al.
Published: (2023-07-01)

Cooperating to Compete in the Global Air Cargo Industry: The Case of the DHL Express and Lufthansa Cargo A.G. Joint Venture Airline ‘AeroLogic’
by: Glenn Baxter, et al.
Published: (2018-03-01)

Anticancer Activity of Propolis and Its Compounds
by: Ewa Forma, et al.
Published: (2021-07-01)

<i>ATP-dependent DNA helicase</i> (<i>TaDHL</i>), a Novel Reduced-Height (<i>Rht</i>) Gene in Wheat
by: Baojin Guo, et al.
Published: (2022-05-01)

TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL
by: PIMJAI NIPARUCK
Published: (2021-10-01)

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
by: Vera Rentsch, et al.
Published: (2022-05-01)

Study on the antioxidant and antitumoral activity of propolis
by: Elisa del Río del Rosal, et al.

Spontaneous Remission and Concomitant Progression in a Patient with DLBCL
by: Eun Ji Han, et al.
Published: (2020-11-01)

Electric Conductivity and Power of Hydrogen Value of Processed Seawater Using a Distillation Tool
by: Muliyadi Muliyadi, et al.
Published: (2021-09-01)

Antitumor Activity of Propolis on Differantiated Cancer Cell Lines
by: Nese Ersoz Gulcelik, et al.
Published: (2012-12-01)

Effect of Turkish propolis extracts on proteome of prostate cancer cell line
by: Barlak Yaşam, et al.
Published: (2011-12-01)

CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements
by: Delin Yuan, et al.
Published: (2021-03-01)

Integration with Transcriptomic and Metabolomic Analyses Reveals the <i>In Vitro</i> Cytotoxic Mechanisms of Chinese Poplar Propolis by Triggering the Glucose Metabolism in Human Hepatocellular Carcinoma Cells
by: Yuyang Guo, et al.
Published: (2023-10-01)

Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement
by: WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua
Published: (2023-09-01)

Allergic Inflammation: Effect of Propolis and Its Flavonoids
by: Nada Oršolić
Published: (2022-10-01)

Development, Physicochemical Properties, and Antibacterial Activity of Propolis Microcapsules
by: Qingya Zhang, et al.
Published: (2023-08-01)

Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP
by: Qian Dong, et al.
Published: (2022-09-01)

Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter’s Trans-Formed DLBCL and Germinal Center B-Cells
by: Barbara Uhl, et al.
Published: (2022-07-01)

Effect of propolis extract on guines pig lung mast cell
by: R. O. Orsi, et al.
Published: (2005-03-01)

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era
by: Dong Won Baek, et al.
Published: (2024-04-01)

Malaria as Potential Aetiology and Treatment Complicating Factor in DLBCL Patient: A Case Report
by: Ibnu Purwanto, et al.
Published: (2023-05-01)

Pengaruh Penggunaan Fly Ash dan Bottom Ash sebagai Cover dalam Pencegahan Pembentukan Air Asam Tambang Menggunakan Metode Free Draining Column Leach Test
by: Muhammad Farhan, et al.
Published: (2021-07-01)

Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients
by: Anna Nydegger, et al.
Published: (2021-12-01)

CD5 and CD43 expression are associate with poor prognosis in DLBCL patients
by: Huang Hui, et al.
Published: (2018-11-01)

Chemical Compositions of Propolis from China and the United States and their Antimicrobial Activities Against <i>Penicillium notatum</i>
by: Xiaolan Xu, et al.
Published: (2019-10-01)

Pseudolaric acid B inhibits the proliferation of human diffuse large B-cell lymphoma cell line SU-DHL-4 via miR-4282
by: YUAN Jun, HAN Hu, DONG Wei, WANG Rui-cang, HAO Hong-ling, ZHANG Xue-jun
Published: (2022-11-01)

Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo
by: Zhenzhen Chen, et al.
Published: (2018-08-01)

Evaluation of BCL6 and MUM1 Expression in Patients with Diffuse Large B Cell Lymphoma (DLBCL) and Their Correlation with Staging and Prognosis of the Disease
by: Hossein Rahimi, et al.
Published: (2015-01-01)

DLBCL 1L—What to Expect beyond R-CHOP?
by: Maike Stegemann, et al.
Published: (2022-03-01)

Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab
by: Irappa Madabhavi, et al.
Published: (2019-04-01)

A Proteomic Approach for Investigation of Bee Products: Royal Jelly, Propolis and Honey
by: Peter Raspor, et al.
Published: (2012-01-01)

The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: a multicentre, non-randomised, open-label phase 2 studyResearch in context
by: Radhakrishnan Ramchandren, et al.
Published: (2023-02-01)

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL
by: Nikeshan Jeyakumar, et al.
Published: (2022-05-01)

The clinicopathological characteristics of gastric cancer and precancerous conditions in gastric DLBCL and MALT lymphoma patients: a multi-center retrospective study
by: Yun Feng, et al.
Published: (2023-12-01)